Who is the boss in the Retinoblastoma family?: The point of view of Rb2/p130, the little brother

被引:0
|
作者
Paggi, MG
Giordano, A
机构
[1] Regina Elena Inst Canc Res, Lab Cell Metab & Pharmacokinet, Ctr Expt Res, I-00158 Rome, Italy
[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Med Coll, Dept Anat, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Jefferson Med Coll, Dept Cell Biol, Philadelphia, PA 19107 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review portrays an updated overview about the possible tumor suppressive properties of the Rb2/p130 gene, the third member of the retinoblastoma (RB) family of genes, including RE itself and p107, After a brief analysis of the established structural and functional similarities among the three genes, the main purpose is to critically analyze present evidence whether Rb2/p130 shares the role of a tumor suppressor. Taking into account the well-proven growth suppressive properties of Rb2/p130 and p107, we discuss the analysis of mutated or deleted forms of Rb2/p130 found in a number of human cancers. Finally, we take into consideration the data provided by the targeted disruption of each RE family gene, alone or in combination, in the mouse model.
引用
收藏
页码:4651 / 4654
页数:4
相关论文
共 50 条
  • [31] Cooperation between p53 and p130(Rb2) in induction of cellular senescence
    A Kapić
    H Helmbold
    R Reimer
    O Klotzsche
    W Deppert
    W Bohn
    Cell Death & Differentiation, 2006, 13 : 324 - 334
  • [32] The RB2/p130 gene:: The latest weapon in the war against lung cancer?
    Claudio, PP
    Caputi, M
    Giordano, A
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 754 - 764
  • [33] Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach
    Gian Marco Tosi
    Carmela Trimarchi
    Marcella Macaluso
    Dario La Sala
    Alfredo Ciccodicola
    Stefano Lazzi
    Mina Massaro-Giordano
    Aldo Caporossi
    Antonio Giordano
    Caterina Cinti
    Oncogene, 2005, 24 : 5827 - 5836
  • [34] Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma:: implications for pathogenesis and therapeutic approach
    Tosi, GM
    Trimarchi, C
    Macaluso, M
    La Sala, D
    Ciccodicola, A
    Lazzi, S
    Massaro-Giordano, M
    Caporossi, A
    Giordano, A
    Cinti, C
    ONCOGENE, 2005, 24 (38) : 5827 - 5836
  • [35] Crosstalk between p53 and p130/Rb2 in induction of an irreversible growth arrest
    Helmbold, H
    Kapic, A
    Reimer, R
    Deppert, W
    Bohn, W
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 : 32 - 32
  • [36] Expression of Rb2/p130 in breast and endometrial cancer:: correlations with hormone receptor status
    Milde-Langosch, K
    Goemann, C
    Methner, C
    Rieck, G
    Bamberger, AM
    Löning, T
    BRITISH JOURNAL OF CANCER, 2001, 85 (04) : 546 - 551
  • [37] Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status
    K Milde-Langosch
    C Goemann
    C Methner
    G Rieck
    A-M Bamberger
    T Löning
    British Journal of Cancer, 2001, 85 : 546 - 551
  • [38] Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer
    Alvi, AJ
    Hogg, R
    Rader, JS
    Kuo, MJ
    Maher, ER
    Latif, F
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2002, 55 (03): : 153 - 155
  • [39] The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence
    Helmbold, Heike
    Galderisi, Umberto
    Bohn, Wolfgang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (02) : 508 - 513
  • [40] RB and RB2/P130 genes cooperate with extrinsic signals to promote differentiation of rat neural stem cells
    Jori, Francesco P.
    Galderisi, Umberto
    Napolitano, Marco A.
    Cipollaro, Marilena
    Cascino, Antonino
    Giordano, Antonio
    Melone, Mariarosa A. B.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2007, 34 (03) : 299 - 309